Blog

Most health FSAs run on the calendar year, the 2026 contribution limit is $3,400, and whatever a patient has not spent by December 31 is forfeited unless their plan offers a carryover (up to $680 into 2027) or a grace period (up to two and a half months). That makes December a real buying moment for a cash-pay telehealth brand. It is also a moment where a careless message can promise eligibility you cannot deliver. Here is what qualifies, what the paperwork needs, and how to say it without pressure tactics.

Thanksgiving is Thursday, November 26, Christmas and New Year's Day both fall on a Friday this year, and USPS recommends shipping Priority Mail by December 18 for delivery before Christmas. For a GLP-1 program, every refill due between November 24 and January 4 needs to move, and every pen in transit has a labeled temperature window. This is the date-by-date runbook: what to ship when, what the labels say about heat and cold, what to tell travelling patients, and how to staff the queue.

There is no trustworthy public benchmark for support tickets per 1,000 telehealth patients, so we built a staffing model you can rebuild with your own numbers. With the assumptions stated below, a 1,000-patient brand without self-serve status needs about 1.2 support and clinical FTEs, and the same brand with portal status, self-serve billing and in-portal cancellation needs about 0.75. Most of the difference is shipping and billing questions that never had to be tickets.

Before the first patient, a DTC telehealth brand needs seven documents: a telehealth informed consent from the medical practice, terms of service, a website privacy policy, a HIPAA Notice of Privacy Practices if the practice is a covered entity, auto-renewal disclosures that satisfy ROSCA and state laws like California's, a consumer health data policy for Washington and Nevada, and pharmacy and medication terms. The tricky part is which entity issues which document. Here is the list, the laws behind each, and the mistakes we see.

A DTC telehealth brand can run with two founders and a handful of contractors up to roughly a thousand patients, provided software does the routing, billing and pharmacy work that used to need an operations team. What does not compress is clinical oversight, support escalations, marketing and compliance review. Here is the role-by-role plan at 0, 300 and 1,000 patients, which roles are contractors and which become hires, and where the platform line sits.

A telehealth refund policy has to answer one question at every stage of the order: has a clinician approved treatment, and has a pharmacy dispensed anything? Before approval there should be nothing to refund; after dispensing, most state pharmacy rules mean the medication cannot come back. This post maps what is refundable at each stage, how cancellation and renewal reminders should work under ROSCA and California's auto-renewal law, how the policy connects to Visa's 1.5% dispute threshold, and ends with policy text you can adapt.

Ten thousand dollars buys a legal telehealth business in one state: the professional corporation, lean counsel, three months of a medical director, first-year insurance, a LegitScript application and a low-cost platform. It does not buy an ad test worth reading, and it does not buy a single line of custom software. Here is the ledger, what to cut and what never to cut, and the one kind of founder for whom $10,000 is enough.

A telehealth subscription is not a SaaS subscription with a doctor attached. The charge has to wait for a clinical approval, the cycle has to follow the pharmacy's fill, the price changes with the dose, and the processor treats the whole category as restricted. Stripe Billing (0.7% of volume), Recurly ($249 a month plus 0.9%) and Chargebee (0.8%, or $99 plus 0.65%) are excellent general billers that know none of that. Here is what each costs at 500 patients, where each breaks on telehealth's six special cases, and when a platform-native engine is the right answer.

The fourth quarter of 2026 has more dated decisions stacked into it than any quarter since the shortage ended: a 503B final order that can land any week, a DEA rule sitting at the White House since August 25, a CagriSema decision, a $199 manufacturer promo that expires December 31, and an open-enrollment season in which employers are quietly dropping GLP-1 coverage. Here is every date we know, what is still undated, and the build item that belongs in front of each one.

Founders on Reddit have stopped asking which platform has the best features and started asking who owns the patient, the records, the card tokens, the pharmacy contract, and the domain when the relationship ends. Those are the right questions, and most sales pages do not answer them. Here are the five ownership dimensions, what each model gives you, the contract language to demand, and where Turbopills stands.

The telehealth platforms are now pitching pharmacies directly ('add virtual care programs to your pharmacy, no extra staff'), and a compounding pharmacy's own trade press warns that clinics without exclusive pharmacy partnerships 'face attrition to CVS, Amazon Pharmacy, and telehealth platforms.' A pharmacy that has watched a third of its GLP-1 volume disappear with the shortage has a choice: rent patients from a platform, sign exclusivity with clinics, or put its own brand on a front end and keep the patient. Here is what the third option requires, from the clinical entity to the storefront, and where the lines are.

Since April 1, 2026, a merchant whose fraud reports plus disputes exceed 1.5% of settled card-not-present transactions is 'excessive' under Visa's Acquirer Monitoring Program, pays $8 per disputed or fraudulent transaction, and becomes a problem for an acquirer that already treats telehealth as a restricted category. For a 500-patient subscription program that is seven bad transactions in a month. Here is how the ratio is counted, where telehealth disputes actually come from, and the billing settings that keep a program under the line.

The pages that rank for 'telehealth CRM' were written in 2022 and 2023 and recommend Salesforce, Zoho and Zendesk to everyone. A DTC telehealth brand has a narrower problem: it needs a system that knows a patient's clinical state, holds protected health information legally, and runs the five workflows that decide conversion and retention, without turning the marketing tool into a medical record. Here are the five realistic options, what each costs in 2026, the test that generic CRMs fail, and what to use at each stage.

On July 29, 2026 the FTC, Utah and Los Angeles County sued Hims & Hers over three things every DTC telehealth brand does or has been tempted to do: charging at intake before a provider has looked at the case, hiding the cancel button, and sending patient events to Meta and Snap. Hims says the claims are baseless and will fight them. Whatever the court decides, the complaint is the clearest checkout specification the category has ever been handed. Here is the spec.

Between September and November, millions of people decide how much pre-tax money to set aside for 2027. A patient who knows your program takes HSA and FSA dollars sizes their election with you in mind; one who finds out in February does not. This is the implementation layer under the strategy: what is eligible with a prescription, what needs a Letter of Medical Necessity, why cards decline, what a clean receipt contains, and how to configure subscriptions so the medical portion survives a claims review.

GLP-1 medication errors are exploding in FDA data, adverse-event counts tied to compounded semaglutide and tirzepatide keep climbing, and FDA warning letters have hit telehealth marketing twice this year. Regulators are now reading DTC programs through a safety lens, and so are patients. The programs that treat side-effect triage as core infrastructure, not a support afterthought, will churn less, spend less on support, and look better in every review and AI answer written about them. Here is how to build that layer.

The medical director is the one hire that gates your launch date, your state map, and your legal structure, and there is no hiring guide for it. Here is where to actually find one, the three compensation models that work, ten interview questions with teeth, and the red flags that should end the conversation.

Ask five founders how much it costs to start a telehealth business and you will get five numbers between $20,000 and half a million, all correct. The variance is not mystery, it is one decision: how much of the stack you assemble yourself. Here is the full line-item budget with real ranges, the self-assembly pile that platforms like Turbopills make disappear, and three worked scenarios from bootstrap single-state to 50 states.

Somewhere in the last year, clinical governance quietly changed jobs. It used to be the thing operators built reluctantly, a cost of doing business. Now it is the thing that wins enterprise partnerships, retail marketplace listings, benefits-consultant referrals, and acquisition interest, because every serious counterparty in telehealth has learned to check. The brands treating governance as a sales asset are closing deals the others never hear about. Here is the reframe, and the build.

Over the next three weeks, the public telehealth companies report Q2, and for one brief window a year, private operators get audited numbers from businesses running the same playbook. Most founders skim the headlines. The better move is structured listening: five metrics, pulled from every call, translated into your own dashboard. Here is the guide, with the questions to ask of each number.